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Introduction
Presynaptic terminals release neurotransmitters in two modes: 
evoked release, which is induced by Ca
2+ fl  owing into the nerve 
terminal when stimulated by an action potential, and spontaneous 
release, which occurs in the absence of massive Ca
2+ infl  ux (Katz, 
1969). Evoked release is clearly the more important form of release 
in terms of how the brain processes information, but many observa-
tions indicate that spontaneous release may also be physiologically 
important, and not just an “accident” of turbocharged presynaptic 
release machinery (for reviews see Otsu and Murphy, 2003; Zucker, 
2005). This evidence suggests that “spontaneous” synaptic vesicle 
exocytosis causing miniature postsynaptic currents (minis) may be 
mechanistically distinct from evoked exocytosis and independently 
regulated, and that minis may have a biological function.
Mechanistically, minis appear to derive from a vesicle 
pool that differs from that which feeds evoked release (Sara 
et al., 2005). Although evoked and spontaneous release both re-
quire SNARE proteins, deletions of the vesicular SNARE pro-
tein synaptobrevin/VAMP2 differentially alter evoked and 
spontaneous release (Deitcher et al., 1998; Schoch et al., 2001), 
and structure/function studies suggest that the sequences of 
  synaptobrevin required for evoked and spontaneous release differ 
(Deak et al., 2006). Moreover, spontaneous and evoked release 
appear to be differentially regulated by Ca
2+ (Llano et al., 2000; 
Angleson and Betz, 2001).
Physiologically, minis may have a substantial function in 
regulating neural networks. In cultured hippocampal slices, block-
ing all release by botulinum toxin had a dramatic effect on spine 
morphology, whereas blocking only evoked release by tetrodo-
toxin did not (McKinney et al., 1999). Similarly, in cultured hippo-
campal neurons, spontaneous release was shown to stabilize 
synaptic function through tonic suppression of dendritic protein 
synthesis (Sutton et al., 2006). In addition, in small cerebellar 
interneurons, a single excitatory or inhibitory quantum, which is 
what is released by a mini event, can trigger or inhibit, respectively, 
the generation of an action potential (Carter and Regehr, 2002).
In synapses of mouse cortical and hippocampal neurons, 
and in Drosophila melanogaster neuromuscular junctions, 
evoked synchronous neurotransmitter release is triggered by 
Ca
2+ binding to synaptotagmin-1 (Geppert et al., 1994; Fernández-
Chacón et al., 2001; Yoshihara and Littleton, 2002; Nishiki 
and Augustine, 2004; Maximov and Südhof, 2005), whereas 
synaptotagmin-2 performs a similar role in brainstem synapses 
(Pang et al., 2006). In addition to mediating synchronous Ca
2+-
triggered release, synaptotagmin-1 and -2 both normally restrict 
spontaneous release (Pang et al., 2006), suggesting that they are 
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intrinsic components of the release machinery. We now fi  nd that 
another member of the synaptotagmin family, synaptotagmin-
12, is colocalized with synaptotagmin-1 on synaptic vesicles, 
but is expressed much later in development. Synaptotagmin-12 
was originally described as a thyroid hormone–inducible pro-
tein (Thompson, 1996) that is homologous to synaptotagmin-1, 
but lacks its Ca
2+-binding sequences, suggesting that it does not 
participate in Ca
2+ triggering of release. We demonstrate that 
expression of synaptotagmin-12 in cultured neurons at a time when 
no endogenous synaptotagmin-12 can be detected causes a dra-
matic and selective increase in spontaneous release. Moreover, 
we show that synaptotagmin-12 is phosphorylated by cAMP-
dependent protein kinase A (PKA) at a single site, and that mu-
tation of this site blocks the effect of synaptotagmin-12 on 
spontaneous release, suggesting that this phosphorylation acti-
vates its up-regulation of spontaneous release. Finally, we dem-
onstrate that synaptotagmin-12 forms a tight constitutive 
complex with synaptotagmin-1 on synaptic vesicles, but regu-
lates spontaneous release independently from synaptotagmin-1. 
Our data suggest a function for a Ca
2+-independent synaptotag-
min isoform in modulating spontaneous release.
Results
Expression of synaptotagmin-12
We generated an antibody against the linker sequence between 
the transmembrane region and C2 domains of synaptotagmin-12. 
As expected from the lack of sequence homology between 
synaptotagmin isoforms in the linker region, the synapto-
tagmin-12 antibody recognized only this isoform, but no 
other synaptotagmin (Fig. 1 A). Immunoblotting revealed that 
synaptotagmin-12 is expressed in the brain and adrenal medulla 
(Fig. 1 B), but not in other nonneuronal tissues tested (Fig. 
1 D), and is also absent from various cell lines, including PC12 
cells (Fig. 1 C).
Analysis of different developmental time points showed 
that synaptotagmin-12 is undetectable during embryonic devel-
opment (embryonic day 18) when synaptotagmin-1 is already 
robustly expressed, is present at very low levels postnatally, 
and becomes abundant after the fi  rst postnatal week (Fig. 1 D). 
Quantitation of the developmental time course of expression 
revealed that synaptotagmin-12 levels increase by  10-fold 
during the second postnatal week (Figs. 1, E and F). This ex-
pression profi  le is very different from that of synaptotagmin-1, 
the levels of which increase less than twofold over the 
same time period, but agrees well with the expression of the 
D. melanogaster synaptotagmin-12 homologue that also exhib-
its low levels throughout embryonic development (Adolfsen 
et al., 2004).
Localization of synaptotagmin-12 
to synaptic vesicles
Immunoblotting of tissue homogenates isolated from various 
regions of adult brain (Fig. 2 A) and immunolabeling of brain 
Figure 1.  Expression of native synaptotagmin-12 in various tissues and neuronal cultures. (A) Lysates of COS7 cells transfected with cDNAs encoding full-
length synaptotagmins 1–13 (Syt 1–13) were analyzed with indicated polyclonal antibodies to various synaptotagmins and valosin-containing protein 
(VCP; used as a loading control). (B–F) Various tissues, cultured cell lines, and primary neuronal cultures were analyzed by immunoblotting with antibodies 
to synaptotagmin-12 (Syt 12), -1 (Syt 1), and VCP as a loading control. Equal amounts of total protein were loaded into each lane. (B) Synaptotagmin-12 
is expressed in adult mouse brain and adrenal medulla. (C) Expression of synaptotagmin-12 could not be detected in cultured cell lines. (D) Analysis of indi-
cated rat tissues isolated at different stages of development ranging from embryonic day 18 to postnatal day 40 (as shown on the right side of each image), 
shows that expression of synaptotagmin-12 is restricted to postnatal brain and displays progressive increase during development. (E and F) Relative expres-
sion levels of synaptotagmin-1 and -12 were determined by quantitative immunoblotting of total brain homogenates isolated from mouse at different stages 
of postnatal development and cortical neurons isolated from newborn mouse pups and cultured in vitro for 5–15 d. (E) Raw immunoblotting data. 
(F) Quantiﬁ  cation of expression with I
125-labeled secondary antibodies. The relative expression levels of each protein were plotted as the percentage of ex-
pression in adult brains (n ≥ 4). Similar results were obtained with cultured hippocampal neurons (not depicted). Data are shown as the mean ± the SEM. SYNAPTOTAGMIN-12 MODULATES SPONTANEOUS RELEASE • MAXIMOV ET AL. 115
sections (Fig. 2 B) revealed that synaptotagmin-12 is abundantly 
expressed throughout the brain, with the highest expression 
levels in cerebellum. This labeling was specifi  c because prein-
cubation with the antigen greatly reduced synaptotagmin-12 
immunoreactivity in brain sections (Fig. 2 C). To establish 
the localization of native synaptotagmin-12, we fractionated the 
brain homogenates and analyzed the distribution of synaptotag-
min-12 in different subcellular fractions. Synaptotagmin-12 
was highly enriched in the fraction that contains synaptic 
vesicles (Fig. 2 D).
Figure 2. Expression and localization of 
synaptotagmin-12. (A) Total homogenates of 
cortex, cerebellum, hippocampus, olfactory 
bulb, brain stem, and spinal cord isolated 
from the brains of adult rats were analyzed 
with antibodies to synaptotagmin-12, -1, 
and VCP (loading control). 20 μg of total 
protein was loaded into each lane. Note 
that synaptotagmin-12 is expressed at dif-
ferent levels in various brain regions, with 
the   highest expression level in cerebellum. 
(B and C) Sections of brains isolated from 
adult mice were labeled with antibody to 
  synaptotagmin-12. (B) Labeling of brain sec-
tions indicates that synaptotagmin-12 is abun-
dantly expressed in various brain regions. 
(C) Brain sections were labeled with antibody 
to synaptotagmin-12 mixed with  1 mg/ml 
recombinant GST-linker fusion protein that 
was used for immunization. Note that 
synaptotagmin-12 immunoreactivity is greatly 
reduced in the presence of the antigen. 
(D) Distribution of native synaptotagmin-12 
in subcellular fractions of adult brain sepa-
rated by centrifugation. Similar to synapto-
tagmin-1 (Syt 1) and synaptobrevin/VAMP2 
(Syb 2), synaptotagmin-12 is enriched in 
synaptic vesicle fraction (crude SVs). Asterisks 
indicate proteolitically cleaved fragment of 
synaptotagmin-1 and various splice variants 
of synaptotagmin-7. (E) Expression of indi-
cated proteins in brains of adult wild-type 
and synapsin double-knockout mice (DKO) 
was analyzed by quantitative immunoblot-
ting with I
125-labeled secondary antibodies. 
(F) The relative expression levels of indicated 
proteins in DKO brains were normalized to VCP 
and presented as the percentage of wild type. 
Note that expression of synaptotagmin-12 and 
other synaptic vesicle proteins is reduced by 
 40%. Data are shown as the mean ± the 
SEM. (G and H) Electron micrographs of 
adult mouse hippocampal sections labeled 
with synaptotagmin-12 antibody alone (G) 
or in the presence of  1 mg/ml of the an-
tigen  (synaptotagmin-12 linker region) used 
for immunization (H). The postsynaptic densi-
ties are marked by white arrowheads. Note 
that synaptotagmin-12 immunoreactivity is 
restricted to presynaptic sites (G; black ar-
rowheads) and inhibited in the presence of the 
antigen (H). (I and J) Localization of recombi-
nant synaptotagmin-12 in cultured hippocam-
pal neurons. The neurons were infected at 5 d 
after plating (5 DIV) with lentivirus express-
ing full-length synaptotagmin-12 cDNA, and 
double labeled at 14 DIV with antibodies to 
synaptotagmin-12 and the dendritic marker 
MAP2 (I; Syt 12, green; MAP2, red) or Syt 12 
and synaptic marker synaptophysin (J; Syt 12, 
green; synaptophysin, red). Inset (I’) illustrates 
enlarged fragment of dendrite marked by white 
box. Note that recombinant synaptotagmin-12 
is concentrated in discrete clusters apposed to 
dendrites and colocalized with synaptophysin. 
Bars: (G) 100 nM; (I and J”) 20 μM.JCB • VOLUME 176 • NUMBER 1 • 2007  116 
Because subcellular fractionation is imprecise, we next 
tested the localization of synaptotagmin-12 by measuring its lev-
els in the brains of synapsin 1/2 double knockout mice. In these 
brains, synaptic vesicles are selectively decreased in numbers, 
and thus the levels of all synaptic vesicle proteins are decreased, 
whereas the levels of other proteins, e.g., active zone proteins, 
plasma membrane proteins, or cytosolic proteins, are unchanged 
(Rosahl et al., 1995). Indeed, we found that synaptotagmin-12 
was reduced by  40% in the synapsin-defi  cient brains, which 
exactly corresponds to the decrease observed for other synaptic 
vesicle proteins (Fig. 2, E and F). The levels of synaptic proteins 
that are not localized on synaptic vesicles, such as the synapto-
tagmin isoforms 3, 6, and 7 or NMDA-  receptors, were not de-
creased in synapsin double knockout mice (Fig. 2, E and F).
To obtain a higher resolution localization, we cultured 
cortical neurons from newborn mice or rats. We fi  rst attempted 
to localize endogenous synaptotagmin-12 in the cultured neu-
rons, but surprisingly, could not detect any synaptotagmin-12 in 
the neurons even after prolonged culture (Fig. 1 E). Quantitations 
of the levels of synaptotagmin-1 and -12 revealed that whereas 
the concentration of synaptotagmin-1 continuously increased in 
the neurons as a function of culture time, synaptotagmin-12 
remained at levels below the sensitivity of our assay, even 
after 15 d in vitro (DIV; Fig. 1 E). Thus, interestingly, synapto-
tagmin-12 is present in cultured neurons below the levels 
observed in the brains from which the neurons were obtained, 
suggesting that additional factors in brain that are absent 
under culture conditions must contribute to the regulation of 
synaptotagmin-12 expression.
To be able to localize synaptotagmin-12 in cultured neu-
rons by immunofl  uorescence labeling, we therefore expressed 
recombinant synaptotagmin-12 with a lentivirus. We found that 
recombinant synaptotagmin-12 was targeted to synapses where 
it precisely colocalized with synaptophysin (Fig. 2, I and J). 
Synaptic vesicle localization of native synaptotagmin-12 was 
supported by immunohistochemical analysis of brain sections 
from adult mice that showed that synaptotagmin-12 is distrib-
uted in a typically synaptic pattern (Fig. S1, available at 
http://www.jcb.org/cgi/content/full/jcb.200607021/DC1), and 
by immunoelectron microscopy that revealed synaptotagmin-12 
immunoreactivity over the vesicle cluster in presynaptic 
terminals (Fig. 2, G and H). Together, these data show that 
synaptotagmin-12 is a synaptic vesicle protein.
Biochemical properties 
of synaptotagmin-12
Vesicular targeting of synaptotagmin-1 is regulated by 
N-glycosylation (Han et al., 2004). To determine whether 
synaptotagmin-12 is also glycosylated, we tested the effects 
of various deglycosylating enzymes on the mobility of native 
  synaptotagmin-12 during SDS-PAGE. In agreement with a previ-
ously published report (Han et al., 2004), removal of neuraminic 
acid and O- and N-linked sugars with sialidase, O-glycanase, 
PNGase, or different combinations of these enzymes resulted in 
a dramatic change in the mobility of synaptotagmin-1, but had 
no effect on the mobility of synaptotagmin-12, suggesting that 
synaptotagmin-12 is not glycosylated (Fig. 3 A). 
To test whether synaptotagmin-12 interacts with phospho-
lipids, we performed phospholipid-binding assays with the re-
combinant C2AB domain of synaptotagmin-12, using the C2AB 
domain of synaptotagmin-1 as a positive control. Consistent 
with the primary sequence analysis that indicated that synapto-
tagmin-12 lacks Ca
2+-binding sequences, no Ca
2+-dependent 
phospholipid binding was observed when the C2AB domain of 
synaptotagmin-12 was tested alone or in the presence of C2AB 
domains of synaptotagmin-1 (Fig. 3 B).
PKA-dependent phosphorylation 
of synaptotagmin-12
A screen of the phosphorylation of different synaptotagmins in 
synaptosomes that were incubated with [
32P]orthophosphate re-
vealed that the strongest labeling with 
32P under the conditions 
used was obtained for synaptotagmin-12 (Fig. 4 B and not 
depicted). To identify which protein kinase may mediate 
  synaptotagmin-12 phosphorylation, we immunoprecipitated 
synaptotagmin-12 from nonlabeled brain extracts and incubated 
the immunoprecipitated synaptotagmin-12 with brain lysate in 
the presence of 1 mM ATP and 10 μCi γ-[
32P]ATP alone or with 
addition of 0.1 mM cAMP, 0.1 mM cGMP, or 1 mM Ca
2+. 
Without additions, no synaptotagmin-12 phosphorylation was 
detected, but cAMP caused strong phosphorylation (Fig. 4 C). 
cGMP induced marginal phosphorylation, possibly because 
cGMP at the high dose used (0.1 mM) can stimulate PKA, 
whereas Ca
2+ did not stimulate any synaptotagmin-12 phos-
phorylation (Fig. 4 C).
We searched the synaptotagmin-12 sequence for potential 
PKA phosphorylation sites and identifi  ed two such sites in the 
Figure 3.  Synaptotagmin-12 is not glycosylated and 
lacks phospholipid binding. (A) Deglycosylation analysis 
of synaptotagmin-12. Proteins from rat brain homogenate 
were treated with sialidase (S), o-glycanase (O), PNGase 
(N), or different combinations of these enzymes to remove 
neuraminic acid and O- and N-linked sugars. The samples 
were then analyzed by immunoblotting with the anti-
bodies to synaptotagmin-1 and -12. Treatment with deglyco-
sylation enzymes results in a substantial change in mobility 
of synaptotagmin-1 in SDS-PAGE, but has no effect on mo-
bility of synaptotagmin-12, indicating that synaptotagmin-12 
is not glycosylated. (B) C2 domains of synaptotagmin-12 
do not bind phospholipids in a Ca
2+-dependent manner. 
Recombinant C2AB domains of synaptotagmins-1 and -12 were expressed as GST-fusion proteins and tested in phospholipid-binding assay at different con-
centrations of free Ca
2+ (as indicated on the top of the gel). Unlike C2 domains of synaptotagmin-1 (Syt 1 C2AB; top), C2 domains of synaptotagmin-12 
(Syt 12 C2AB) do not bind phospholipids when tested alone or in the presence of Syt 1 C2AB.SYNAPTOTAGMIN-12 MODULATES SPONTANEOUS RELEASE • MAXIMOV ET AL. 117
synaptotagmin-12 linker region (T87 and S97; Fig. 4 A). To de-
termine whether one or both of these are being used, we fi  rst 
tested whether recombinant fragments of synaptotagmin-12, 
produced as GST-fusion proteins, were phosphorylated by PKA. 
Only the linker region, but not the C2 domains, were phosphory-
lated (Fig. 4 D). We next tested whether mutation of either T87 
or S97 alters phosphorylation of the linker by PKA. We found 
that phosphorylation was completely abolished by substituting 
serine
97 with alanine, whereas substituting threonine
87 with ala-
nine had no effect (Fig. 4 E), suggesting that synaptotagmin-12 
is phosphorylated by PKA on serine
97. To   determine whether the 
PKA phosphorylation site in synaptotagmin-12 is evolutionarily 
conserved, we compared the linker sequences from different 
species. Although no signifi  cant homology was found between 
fl  y and vertebrate synaptotagmin-12 linker sequences (unpub-
lished data), serine
97 with a   canonical pre  ceding lysine residue 
was found to be conserved in all vertebrate synaptotagmin-12 
homologues from zebrafi  sh to   humans (Fig. 4 F).
Synaptotagmin-12 modulates spontaneous, 
but not evoked, release
We next explored whether synaptotagmin-12 regulates synaptic 
transmission using cultured cortical neurons isolated from new-
born mice or rats. Because the cultured neurons do not contain 
any detectable synaptagmin-12, even after prolonged culture (Fig. 
1, E and F), the cultured neurons resemble a synaptotagmin-12 
loss-of-function model. We infected the neurons with lenti-
viruses encoding full-length wild-type or S97A mutant synapto-
tagmin-12 and compared the expression levels of recom  binant 
proteins after 15 DIV (and 10 d after lentivirus infection) with 
the levels of native synaptotagmin-12 in noninfected cultures 
and in brain (Fig. 5 A). We found that recombinant wild-type 
and S97A mutant synaptotagmin-12 were expressed in cul-
tured neurons at equal levels, i.e., were properly translated, 
with an approximately sixfold higher concentration than that of 
synaptotagmin-12 in P15 brain (Fig. 5 B).
Both wild-type and S97A mutant synaptotagmin-12 were 
targeted to synapses (Fig. 2 J and not depicted). When com-
pared with noninfected neurons, the neurons infected with syn-
aptotagmin-12 lentiviruses did not display signifi  cant changes 
in general morphology, and the levels of endogenous synaptic 
proteins (Fig. 5, A and C, and not depicted). To test whether 
expressed synaptotagmin-12 is phosphorylated under physio-
logical conditions, we analyzed noninfected neurons and neu-
rons infected with wild-type and S97A mutant synaptotagmin-12 
lentiviruses by immunoprecipitation. We labeled the neurons 
with [
32P]orthophosphate, lysed them, and measured 
32P 
incorporation into immunoprecipitated synaptotagmin-12. 
Signifi  cant synaptotagmin-12 phosphorylation was only de-
tected in neurons expressing wild-type synaptotagmin-12, 
whereas noninfected neurons and neurons expressing mutant 
synaptotagmin-12 exhibited no signifi  cant 
32P labeling (Fig. 
5 A, bottom). These data suggest that under the conditions used, 
synaptotagmin-12 is phosphorylated only on serine
97 either be-
cause another constitutively active protein kinase phosphory-
lates this amino acid or because, in these cultured neurons, 
PKA is activated.
Figure 4.  Synaptotagmin-12 is phosphorylated in a cAMP-dependent 
manner at serine
97. (A) Schematic diagram of synaptotagmin-12 domain 
structure. A fragment of linker sequence containing two putative sites for 
PKA-dependent phosphorylation (T87 and S97, marked by asterisks) is 
  illustrated below. (B) In vivo phosphorylation of native synaptotagmin-12. 
The proteins from rat brain synaptosomes preincubated with 
[
32P]orthophosphate were extracted in detergent and immunoprecipitated 
with antibody to synaptotagmin-12 or preimmune serum. Incorporation of 
32P was measured with x-ray ﬁ  lm. Note that a single  50-kD band is ob-
served in synaptotagmin-12, but not in control immunoprecipitation. 
(C) In vitro phosphorylation of native synaptotagmin-12. Proteins extracted 
from brain were immunoprecipitated with synaptotagmin-12 antibody or 
preimmune serum attached to Sepharose beads. The beads were incu-
bated with brain cytosol mixed with 1 mM ATP and 10 μCi γ-[
32P]ATP 
alone or with addition of 0.1 mM cAMP, 0.1 mM cGMP, or 1 mM Ca
2+. 
Note that synaptotagmin-12 is strongly phosphorylated in a cAMP-
  dependent manner. (D and E) Identiﬁ  cation of a functional PKA phosphory-
lation site in synaptotagmin-12 sequence. (D) Indicated fragments of 
synaptotagmin-12 were expressed as recombinant GST fusion proteins 
(top shows Coomassie staining of all fusion proteins; the asterisk corre-
sponds to GST) and phosphorylated in vitro in the presence of catalytic 
subunit of PKA and γ-[
32P]ATP. Note that only linker region of synaptotag-
min-12 is phosphorylated. (E) Phosphorylation of wild-type synaptotagmin-
12 linker GST fusion protein and linkers containing single alanine 
substitutions in residues T87, S97, or a combination of these mutations. 
Note that phosphorylation is completely abolished in S97A mutant. The aster-
isk corresponds to GST. (F) Multiple sequence alignment of synaptotagmin-12 
homologues from different species shows the fragments of the linker sequences 
containing conserved PKA phosphorylation site (marked by black boxes).JCB • VOLUME 176 • NUMBER 1 • 2007  118 
To determine whether synaptotagmin-12 regulates evoked 
or spontaneous neurotransmitter release, we monitored inhibi-
tory postsynaptic currents (IPSCs) in noninfected neurons or 
neurons expressing recombinant wild-type or S97A mutant 
synaptotagmin-12. We found that expression of wild-type 
  synaptotagmin-12 increased the frequency of spontaneous re-
lease events threefold, but had no effect on their amplitude 
(Fig. 5, D–G). In contrast to spontaneous minis, synaptotag-
min-12 had no effect on the sizes or kinetics of evoked re-
sponses, either when these were elicited by isolated single-action 
potentials or by high-frequency stimulus trains, indicating that 
both synchronous and asynchronous components or evoked re-
lease were unaffected (Fig. 6). Importantly, expression of S97A 
  mutant synaptotagmin-12 had no effect on spontaneous release 
(Fig. 5, D and E), even though the mutant protein was expressed 
at the same level as wild-type synaptotagmin-12 (Fig. 5, A 
and B).
Several previous studies indicated that spontaneous re-
lease is up-regulated by cAMP-dependent pathways (Chavez-
Noriega and Stevens, 1994; Capogna et al., 1995; Yoshihara et al., 
2000; Doi et al., 2002). To test the possibility that the   effect 
of synaptotagmin-12 on spontaneous release—which   depends 
on the PKA-substrate site at serine
97—intersects with the PKA-
dependent regulation of spontaneous release, we examined the 
effect of forskolin (an activator of adenylate cyclase) on sponta-
neous release. We found that in control cultures, forskolin caused 
an  4.5-fold increase in the rate of spontaneous release (Fig. 
5, D and E), but had no effect on evoked release (Fig. S2, avail-
able at http://www.jcb.org/cgi/content/full/jcb.200607021/DC1). 
In cultures expressing wild-type synaptotagmin-12, the increase in 
mini frequency induced by forskolin was much more potent 
than in control cultures, whereas in   cultures expressing S97A 
mutant synaptotagmin-12, the effect of forskolin was identi-
cal to that observed in control cultures (Fig. 5, D and E).
Figure 5.  Synaptotagmin-12 regulates spontaneous trans-
mitter release. (A) Analysis of expression and phosphoryla-
tion of native and recombinant synaptotagmin-12 in cultured 
cortical neurons. Noninfected neurons or neurons infected 
with wild-type or S97A synaptotagmin-12 lentiviruses were 
analyzed by immunoblotting with antibodies to synaptotag-
min-12, -1, Rab3, and VCP as a loading control. Radioimmuno-
precipitation analysis (bottom) shows that recombinant 
wild-type synaptotagmin-12 is phosphorylated in cultured 
neurons and phosphorylation is abolished in S97A mutant. 
(B and C) Expression levels of synaptotagmin-12 and -1 in 
noninfected neurons and neurons infected with wild-type and 
S97A synaptotagmin-12 lentiviruses were determined by 
quantitative immunoblotting with I
125-labeled secondary anti-
bodies, normalized to VCP, and plotted as the percentage of 
expression in P15 brains. (D–G) Overexpression of wild-type 
synaptotagmin-12 increases the rate of spontaneous release 
in inhibitory synapses. Spontaneous mIPSCs were monitored 
in the absence or presence of 50 μM forskolin from non-
infected neurons (control) or neurons infected with the lentivi-
ruses expressing wild-type synaptotagmin-12 or S97A mutant. 
mIPSCs were recorded in the presence of CNXQ and APV to 
block excitatory responses and Tetrodotoxin (TTX) to block 
spontaneous ﬁ  ring. (D) Typical mIPSCs recorded from control 
neurons (shown in black) or neurons infected with wild-type 
(shown in blue) or S97A (shown in red) synaptotagmin-12 
lentiviruses. mIPSCs were recorded in control conditions 
(traces 1–3) or in the presence of forskolin (traces 4–6). Scale 
bars apply to all traces. (E) Mean frequencies of mIPSCs moni-
tored in various conditions (indicated on the bottom of the 
graph) from three different cortical cultures. The total numbers 
of analyzed neurons are shown on each column. (F and G) 
Overexpression of synaptotagmin-12 does not affect the 
  amplitudes of spontaneous mIPSCs. F shows a cumulative 
ampli  tude histogram constructed from 550 individual mIPSCs 
collected from control noninfected neurons and neurons 
  infected with wild-type and S97A synaptotagmin-12 lentivi-
ruses, and G shows the plot of average mIPSC amplitudes. 
For each group, n ≥ 12 neurons (data from three indepen-
dent cultures). Data are shown as the mean ± the SEM. SYNAPTOTAGMIN-12 MODULATES SPONTANEOUS RELEASE • MAXIMOV ET AL. 119
Synaptotagmin-12 binding 
to synaptotagmin-1
To obtain clues to the mechanism of action of synaptotagmin-12 
in its selective effect on spontaneous release, we investigated 
whether synaptotagmin-12 might interact with SNARE proteins 
because binding to SNARE proteins is a salient property of 
other synaptotagmins (Bennett et al., 1992; Yoshida et al., 1992; 
Li et al., 1995; Chapman et al., 1995; Kee and Scheller, 1996; 
Banerjee et al., 1996; Rickman and Davletov, 2003; Rickman 
et al., 2004; Bowen et al., 2005; Tang et al., 2005). We performed 
immunoprecipitations of detergent-solubilized brain proteins 
with antibodies to synaptotagmin-1 and -12, and analyzed the 
immunoprecipitates for the presence of SNARE proteins and 
synaptotagmins. These experiments failed to reveal binding 
of synaptotagmin-12 to SNARE proteins, but showed that 
synaptotagmin-1 was coimmunoprecipitated with synaptotagmin-12 
(Fig. 7 A), and that synaptotagmin-12 was coimmunoprecipi-
tated with synaptotagmin-1 (Fig. 7 B). SNARE proteins were 
selectively absent from the synaptotagmin-12 immunopre-
cipitates, but were present in the synaptotagmin-1 immuno-
precipitates. Equal amounts of synaptotagmin-1 and -12 were 
coimmunoprecipitated in the presence of either 1 mM free Ca
2+ 
or EGTA, suggesting that the interaction between these pro-
teins is Ca
2+-independent (Fig. 7, A and B). Quantitations re-
vealed that the equal amounts of synaptotagmin-1 and -12 were 
  coimmunoprecipitated from nontreated brain homogenates and 
homogenates preincubated with PKA activator 8-Br-cAMP 
(1 mM), PKA inhibitor H-89 (5 μM), or PKC activator PDBu 
(1 μM), suggesting that interaction between synaptotagmin-1 
and -12 is not regulated by phosphorylation (Fig. 7, C–F).
Synaptotagmin-12 regulates spontaneous 
release independent of synaptotagmin-1
To determine whether synaptotagmin-12 regulates spontaneous 
release through interaction with synaptotagmin-1, we infected 
cortical neurons isolated from newborn synaptotagmin-1–  defi  cient 
Figure 6.  Analysis of evoked IPSCs in neurons expressing synaptotagmin-12. Primary cortical neurons isolated from newborn pups were infected with lenti-
virus expressing wild-type synaptotagmin-12 and analyzed at 14–17. DIV Noninfected neurons or neurons infected with GFP-lentivirus were used as a con-
trol. Inhibitory synaptic responses were evoked by local extracellular stimulation and recorded in a whole-cell mode. AMPA and NMDA currents were 
suppressed by the addition of CNQX and APV to the extracellular bath solution. Recordings were performed in 0.5 or 2 mM extracellular Ca
2+. The holding 
potential was –70 mV. The data are shown as the mean ± the SEM. (A–D) Amplitudes and the time course of individual IPSCs recorded form control neurons 
(shown in black) or neurons infected with synaptotagmin-12 lentivirus (shown in blue). IPSCs were triggered by single-action potentials applied at low fre-
quency (0.1 Hz). (A and B) IPSCs recorded in 0.5 (A) or 2 mM (B) extracellular calcium from the neurons cultured for 14–16 DIV. The scale bars apply to 
all traces. (C) Mean amplitudes of IPSCs monitored in indicated concentrations of extracellular calcium from three different cortical cultures. The total numbers 
of analyzed neurons are shown on each column. (D) Cumulative histograms illustrate the time course of total charge transferred over 1.5 s after single-action 
potential stimulation. (E) Paired pulse IPSC ratios measured in 2 mM extracellular calcium in control neurons and neurons infected with   synaptotagmin-12 
lentivirus. IPSCs were triggered by two action potentials spaced by various interpulse periods, as indicated on the plot. Control, n = 10; Syt 12, n = 11. 
(F and G) Typical inhibitory responses recorded in 0.5 (F) or 2 mM (G) extracellular calcium from control (current traces on the top, shown in black) or synap-
totagmin-12–infected neurons (current traces on the bottom, shown in blue) triggered by 100 action potentials applied at 10 Hz. The scale bars apply to all 
traces. The plots on the bottom show the average amplitudes of synchronous IPSCs during stimulus trains. (H) Average total charges transferred during trains 
of 100 action potentials applied at 10 Hz. The total numbers of analyzed neurons are shown on each column. Data are shown as the mean ± the SEM.JCB • VOLUME 176 • NUMBER 1 • 2007  120 
mice (Geppert et al., 1994) with lentiviruses expressing wild-type 
and S97A mutant synaptotagmin-12. We then monitored spontane-
ous release and release triggered by action potentials (Fig. 8). 
Because deletion of synaptotagmin-1 results in an in-
crease in the rate of spontaneous release (Maximov and 
Südhof, 2005; Pang et al., 2006,), we measured spontaneous 
release in a lower concentration of extracellular Ca
2+ that al-
lows us to resolve individual miniature IPSC events. We found 
that similar to wild-type neurons, expression of synaptotagmin-12 
in synaptotagmin-1–defi   cient neurons enhanced the rate of 
spontaneous release (Fig. 8, E and F), but did not alter evoked 
release triggered by action potentials (Fig. 8, A–D). Because 
evoked release is completely asynchronous in synaptotagmin-1–
defi  cient neurons (Maximov and Südhof, 2005), synaptotagmin-
12, thus, does not significantly alter asynchronous release. 
  Although the increase in spontaneous release in synaptotagmin-1–
defi  cient neurons expressing synaptotagmin-12 was not as 
dramatic as in wild-type cultures, the increase was still de-
pendent on the phosphorylation of synaptotagmin-12 because 
the S97A mutant synaptotagmin-12 was unable to potentiate 
the mini IPSC (mIPSC) rate (Fig. 8, E and F). In these ex-
periments, we could not determine the effects of forskolin on 
mIPSC frequency because the rate of spontaneous release was 
already too high.
Discussion
In this study, we demonstrate that synaptotagmin-12 is a synap-
tic vesicle protein that is widely expressed in the brain with a 
developmentally delayed onset (Fig. 1). Although synaptotagmin-
12 is highly homologous to synaptotagmin-1 (which functions 
as the Ca
2+ sensor for fast synaptic vesicle exocytosis), and is 
colocalized with synaptotagmin-1 on synaptic vesicles (Fig. 2 
and Fig. S1), synaptotagmin-12 differs from synaptotagmin-1 
in that it does not bind Ca
2+ and phospholipids (Fig. 3 and not 
depicted). We also demonstrate that it is phosphorylated in a 
Figure 7.  Synaptotagmin-12 forms a Ca
2+-
independent complex with synaptotagmin-1. 
Brain proteins were extracted in 1% of Triton 
X-100 and immunoprecipitated with polyclonal 
antibody to synaptotagmin-12 (A), monoclonal 
antibody to synaptotagmin-1 (B), correspond-
ing preimmune serum or irrelevant control anti-
body in the presence of 1 mM Ca
2+ or EGTA. 
Immunoprecipitates were extensively washed 
and analyzed by immunoblotting with various 
antibodies, as indicated on the right side of each 
image. Input lines were loaded with 1% of total 
protein extract used for immunoprecipitation. 
(A) Synaptotagmin-1, but not SNARE, proteins 
are coimmunoprecipitated with synaptotag-
min-12. (B) Synaptotagmin-12 and syntaxin-1 
are coimmunoprecipitated with synaptotag-
min-1 in a Ca
2+-independent manner. (C–F) 
Synaptotagmin-1 and -12 were coimmunopre-
cipitated form nontreated brain homogenates 
or homogenates incubated with PKA activator 
8-Br-cAMP (1 mM), PKA inhibitor H-89 (5 μM), 
or PKC activator PDBu (1 μM). Immunoblots 
(C and D) and protein quantiﬁ  cations with I
125-
labeled secondary antibodies (E and F) show the 
relative amounts of synaptotagmin-1 and -12 
in total protein extracts and immunoprecipita-
tions under indicated conditions. Data are 
shown as the mean ± the SEM. SYNAPTOTAGMIN-12 MODULATES SPONTANEOUS RELEASE • MAXIMOV ET AL. 121
cAMP-dependent manner at a single residue, serine
97 (Fig. 4). 
Because it is expressed in a developmentally delayed pattern, 
cultured neurons contain very low levels of endogenous synap-
totagmin-12. Overexpression of recombinant synaptotagmin-12 
in these neurons dramatically increased the rate of spontaneous 
release (Fig. 5), but had no effect on synchronous and 
  asyn  chronous components of release triggered by action 
 potentials  (Fig. 6).
At least two alternative hypotheses could potentially 
  explain how synaptotagmin-12 controls spontaneous neuro-
transmitter release: (1) synaptotagmin-12 regulates spontane-
ous release via its interaction with synaptotagmin-1, and (2) 
synaptotagmin-12 acts as an independent modulator of sponta-
neous release.
The fi  rst hypothesis is supported by the observation 
that synaptotagmin-12 forms a constitutive Ca
2+-independent 
heterooligomeric complex with synaptotagmin-1 that is incom-
patible with the interaction of synaptotagmin-1 with SNARE 
complexes (Fig. 7). Previous studies indicate that synaptotagmin-1 
is associated with SNARE complexes in a Ca
2+-independent 
manner (Kee and Scheller, 1996; Rickman and Davletov, 2003), 
and that deletion of synaptotagmin-1 increases the rate of excit-
atory and inhibitory minis (Maximov and Südhof, 2005; Pang 
et al., 2006), suggesting that freeing SNARE complexes from 
synaptotagmin-1 may disinhibit spontaneous release. Our fi  nd-
ing that synaptotagmin-12 interacts with synaptotagmin-1 
suggests that synaptotagmin-12 increases spontaneous neurotrans-
mitter release by pulling synaptotagmin-1 off SNARE com-
plexes, and thereby disinhibiting spontaneous exocytosis. The 
alternative hypothesis would be that that synaptotagmin-12 reg-
ulates spontaneous release by a synaptotagmin-1–independent 
(but phosphorylation-dependent) mechanism, and that the inter-
action of synaptotagmin-12 with synaptotagmin-1 performs an 
additional, as yet undetermined, role.
To test the two hypotheses, we determined the effect of 
overexpression of synaptotagmin-12 in synaptotagmin-1–
 defi  cient neurons (Fig. 8). We found that in the absence of 
  synaptotagmin-1, synaptotagmin-12 still produced an increase, 
albeit a moderate one, in the rate of spontaneous exocytosis. 
This result favors the second hypothesis, suggesting that the 
phosphorylation site–dependent modulation of mini release by 
synaptotagmin-12 does not require synaptotagmin-1. It is also 
unlikely that the effect of expression of synaptotagmin-12 on 
spontaneous release is caused by a massive change in synapse 
density or in the size of the readily releasable pool of synaptic 
vesicles because we observed no differences between neurons 
expressing or lacking wild-type or mutant synaptotagmin-12 in 
evoked synaptic responses; this applies both for responses trig-
gered by single-action potentials or by trains of action poten-
tials (Figs. 6 and 8). A recent study has shown that spontaneous 
release is driven by an isolated pool of synaptic vesicles containing 
synaptotagmin-1 and controlled by synaptobrevin/VAMP2 
(Sara et al., 2005). It is conceivable that synaptotagmin-12 se-
lectively regulates spontaneous release because it is only local-
ized on this subpopulation of vesicles, but further biochemical 
analysis with an antibody against the luminal domain of synap-
totagmin-12 will be required to test this possibility.
Our fi  ndings have several implications for the understand-
ing of synaptic transmission. First, the possible biological role 
of spontaneous release events is widely debated, with opinions 
ranging from considering such events as mere accidental by-
products of turbo-charged fusion machinery to biologically 
Figure 8.  Synaptotagmin-12 regulates spontaneous transmitter release 
independently from synaptotagmin-1. Primary cortical neurons isolated 
from newborn pups of synaptotagmin-1–deﬁ  cient mice were infected with 
lentiviruses expressing GFP (control), wild-type synaptotagmin-12, or S97A 
mutant and analyzed at 15–17 DIV. (A–D) Evoked IPSCs triggered in 
2 mM of extracellular Ca
2+ by single-action potentials or trains of 100 ac-
tion potentials applied at 10 Hz. (A) Typical asynchronous IPSCs triggered 
by single-action potentials in control neurons (black) or neurons express-
ing wild-type synaptotagmin-12 (blue). Scale bars apply to both traces. 
(B) Average charge transferred over 1.5 s by asynchronous responses trig-
gered by single action potentials. The total numbers of analyzed neurons 
are shown on each column. (C) Asynchronous responses triggered by 
high frequency trains of 100 action potentials applied at 10 Hz. Scale 
bars apply to both traces. (D) Average total synaptic charge transfer dur-
ing trains or 100 potentials in control neurons or neurons expressing wild-
type synaptotagmin-12. The total numbers of analyzed neurons are shown 
on each column. (E and F) Synaptotagmin-12 increases the rate or sponta-
neous release in synaptotagmin-1–deﬁ  cient neurons. (E) Typical mIPSCs 
recorded from control neurons (black) or neurons infected with wild-type 
(blue) or S97A (red) synaptotagmin-12 lentiviruses. mIPSCs were recorded 
in 0.2 mM of extracellular Ca
2+ in the presence of tetrodotoxin, APV, and 
CNQX. Scale bars apply to all traces. (F) Average frequencies of mIPSCs 
monitored from two different cortical cultures. The total numbers of ana-
lyzed neurons are shown on each column. Data are shown as the mean ± 
the SEM. JCB • VOLUME 176 • NUMBER 1 • 2007  122 
meaningful processes of synaptic communication  (Otsu and 
Murphy, 2003; Zucker, 2005). Our data, by identifying a synap-
tic vesicle synaptotagmin isoform that selectively regulates 
spontaneous release in cultured neurons, lend credence to the 
notion that spontaneous release is a highly specifi  c and regu-
lated event. Notably, the rate of spontaneous release increases 
with age (Hsia et al., 1998), as do the expression levels of 
 synaptotagmin-12.  This  fi  nding suggests a connection, but sev-
eral other factors such as developmental changes in connectiv-
ity and synapse maturation must also play a major role in this 
process (Hsia et al., 1998).
Although the effect of synaptotagmin-12 in cultured neu-
rons is specifi  c for spontaneous as opposed to evoked release, 
this does not exclude the possibility that in an intact brain, 
synaptotagmin-12 could participate in PKA-dependent forms of 
plasticity. It is noticeable that synaptotagmin-12 was discovered 
as a thyroid hormone–inducible gene (Thompson, 1996; Dong 
et al., 2005) and comes on relatively late in development, sug-
gesting that its role is under further regulation beyond the phos-
phorylation by PKA. Moreover, extensive studies indicate that 
cAMP-dependent phosphorylation regulates exocytosis in non-
neuronal cells (Koh et al., 2000) and neurons (Chavez-Noriega 
and Stevens, 1994; Capogna et al., 1995; Yoshihara et al., 2000; 
Doi et al., 2002). Multiple pathways have been implicated in the 
cAMP-dependent modulation of synaptic strength (Chavez-
Noriega and Stevens, 1994; Capogna et al., 1995; Carroll et al., 
1998; Sakaba and Neher, 2001; Kaneko and Takahashi, 2004). 
The requirement of serine
97 for the effect of synaptotagmin-12 
on spontaneous release indicates that synaptotagmin-12 may be 
generally involved in the regulation of synaptic vesicle exocyto-
sis by PKA-dependent phosphorylation. Finally, expression of 
synaptotagmin-12 was detected in adrenal glands (Fig. 1 B), 
suggesting that synaptotagmin-12 may also be localized on 
dense core vesicles and play a role in regulating calcium-
  independent secretion in nonneuronal cells.
Materials and methods
Plasmid construction
The following vectors were constructed for expression of various regions of 
rat synaptotagmin-12 as GST-fusion proteins: pGEX-KG-synaptotagmin-12-
linker (aa 47–150); pGEX-KG-synaptotagmin-12-C2A (aa 151–281); 
and pGEX-KG-synaptotagmin-12-C2B (aa 282–421). For construction of 
synaptotagmin-12 lentivirus, full-length cDNA (aa 1–421) was subcloned 
into pFUGW shuttle vector. The point mutations were generated by PCR 
and veriﬁ  ed by sequencing.
Antibody production
To generate a polyclonal antibody against synaptotagmin-12, the linker re-
gion of rat synaptotagmin-12 (aa 47–150) was expressed in BL-21 
Escherichia coli strain as GST fusion protein and puriﬁ  ed by afﬁ  nity chro-
matography on glutathione–Agarose beads (GE Healthcare). The protein 
was eluted from the beads by 20 mM glutathione, dialyzed twice against 
PBS, and used for immunization at concentration of  1 mg/ml. The speci-
ﬁ  city of the serum was conﬁ  rmed by immunoblotting of full-length recombi-
nant synaptotagmins 1–13 expressed in COS7 cells. The antibody was 
then puriﬁ  ed by sequential afﬁ  nity chromatography on the columns con-
taining GST and GST-synaptotagmin-12-linker covalently attached to 
NHS–Sepharose beads (Pierce Chemical Co.)
Subcellular fractionation
Whole rat brains, including cerebellum and olfactory bulb, were homoge-
nized in 0.32 M sucrose, 25 mM Hepes, pH 7.2, and centrifuged at 800 g 
to remove the nuclear fraction. The postnuclear supernatant (LSP) was cen-
trifuged at 12,000 g to separate the soluble (synaptosomal supernatant) 
and membrane (synaptosomal pellet) fractions. The synaptosomal pellet 
was hypotonically lysed by incubation for 30 min in 5 mM Tris, pH 7.2, 
and recentrifuged at 27,000 g to separate the crude synaptic plasma 
membranes and crude synaptic vesicles. The crude synaptic plasma mem-
brane fraction was adjusted to 1.1 M sucrose, loaded to the bottom of the 
centrifuge tube, and layered by solutions of 0.86 and 0.32 M sucrose. The 
samples were then centrifuged at 19,000 RPM (SW41 Ti rotor; Beckman 
Coulter) to separate synaptic plasma membranes, myelin, and mitochondria. 
All fractions were adjusted to the total protein concentration of 4 mg/ml and 
analyzed by immunoblotting. Approximately 40 μg of total protein was 
loaded into each lane (Fig. 3 C).
Immunoprecipitations
Rat brains were homogenized in 50 mM Hepes, 100 mM NaCl, 2 mM 
MgCl2, 4 mM EGTA, pH 6.8, and solubilized for 2 h at 4°C in the same 
buffer containing 1% Triton X-100. The samples were then centrifuged for 
1 h at 50,000 RPM (70 Ti rotor; Beckman Coulter) to remove insoluble ma-
terial and incubated for 2 h at 4°C with protein A–or protein G–Sepharose 
beads (GE Healthcare) covered with polyclonal antibody to synaptotagmin-
12, monoclonal antibody to synaptotagmin-1, corresponding preimmune 
serum, or control antibody. The protein complexes attached to the beads 
were washed ﬁ  ve times with the extraction buffer, eluted with SDS sample 
buffer, and analyzed by SDS-page and immunoblotting. The input lanes 
were loaded with 1% of total protein extract used for immunoprecipitation. 
To determine the effects of activators or inhibitors of PKA-dependent phos-
phorylation, the brain homogenates were preincubated for 30 min with 
1 mM 8-Br-cAMP, 5 μM H-89, or 1 μM PDBu (used as a negative control) 
before protein extraction, and the immunoprecipitations were carried in 
the presence of EGTA, as described above.
Cortical and hippocampal primary neuronal cultures
The cortexes or hippocampi were dissected from the brains of embryonic 
day 18 embryos or newborn pups, dissociated by trypsin digestion, and 
plated on circle glass coverslips coated with Matrigel. The cultures were 
maintained in MEM medium (Invitrogen) supplemented with B-27 (Invitro-
gen), L-glutamine, 0.5% glucose, 5% fetal bovine serum, and 2 mM Ara-C 
(Sigma-Aldrich). The cultures were used for experiments at 14–17 DIV.
Immunocytochemistry
Neurons attached to the glass coverslips were rinsed once in PBS, ﬁ  xed for 
15 min on ice in 4% formaldehyde, 4% sucrose in PBS and permeabilized 
for 5 min at room temperature in 0.2% Triton X-100 (Roche) in PBS. After 
permeabilization, the neurons were incubated for 30 min in blocking solu-
tion containing 5% BSA (Sigma-Aldrich; fraction V) in PBS, followed by 1-h 
incubation with primary and rhodamine- and FITC-conjugated secondary 
antibodies diluted in blocking solution. The coverslips were then mounted 
on glass slides with Aqua-Poly/Mount medium (Polysciences, Inc.) and an-
alyzed at room temperature using a confocal microscope (DMIRE2; Leica) 
and 63×/1.32–0.6 oil immersion objective. The images were collected 
using confocal software (Leica) and processed using Photoshop software 
(Adobe). The background ﬂ  uorescence was digitally reduced by 25% us-
ing the “color balance” function in Photoshop. All digital manipulations 
were equally applied to the entire image. Brain sections from perfusion-
ﬁ  xed rats were permeabilized for 10 min in 0.5% Triton X-100 in PBS and 
incubated in blocking buffer containing 2% goat serum and 0.1% Triton 
X-100 in PBS. The sections were then incubated sequentially for 1 h in pri-
mary and secondary antibodies diluted in blocking buffer and developed 
in DAB substrate. For dehydration, the sections were incubated for 10 min 
in 70% ethanol, followed by 10-min incubation in 90% ethanol and 10-
min incubation in 100% ethanol. The sections were then mounted on glass 
slides and analyzed by light microscopy.
Immunoelectron microscopy
Adult mouse brains were perfusion ﬁ   xed in 4% paraformaldehyde and 
0.1% glutaraldehyde in PBS, pH 7.4, followed by overnight immersion ﬁ  x-
ation in 0.1% glutaraldehyde and 2% paraformaldehyde. The brain sec-
tions (120 μm) were permeabilized in 0.2% Triton X-100, blocked in 4% 
normal goat serum, and incubated overnight with primary antibody alone 
or primary antibody mixed with the antigen ( 1 mg/ml). The sections 
were then incubated with the secondary antibody conjugated with 1.4-nm 
gold particles (1:100 dilution; Nanoprobes) for 24 h, and immunogold 
signal was enhanced with the HQ silver enhancement kit (Nanoprobes). 
Sections were further ﬁ   xed with 0.5% osmium tetroxide, dehydrated SYNAPTOTAGMIN-12 MODULATES SPONTANEOUS RELEASE • MAXIMOV ET AL. 123
through a graded series of ethanol, and embedded in Poly/Bed 812 ep-
oxy resin (Polysciences, Inc.). Ultrathin sections (65 nm) were stained with 
5% uranyl acetate solution and examined under a transmission electron 
microscope (FEI Tecnai; FEI) at 120 kV accelerating voltage.
Phosphorylation
Synaptosomes ( 1 mg of total protein) were prelabeled for 30 min at 
37°C in phosphate-free aerated Krebs-Henseleit-Hepes buffer (118 mM 
NaCl, 3.5 mM KCl, 1.25 mM CaCl2, 1.2 mM MgSO4, 25 mM, NaHCO3, 
5 mM Hepes-NaOH, pH 7.4, and 115 mM glucose) containing 0.3 mCi 
of [
32P]orthophosphate and incubated for an additional 10 min with 1 μM 
of okadaic acid. 
32P-labeled synaptosomes were precipitated by centrifu-
gation at 14,000 rpm on a microcentrifuge (Eppendorf) and solubilized for 
1 h at 4°C in Krebs-Henseleit-Hepes buffer containing 2 mM sodium or-
thovanadate, 10 mM sodium pyrophosphate, 50 mM NaF, 1 mM EGTA, 
1 mM EDTA, 1% Triton X-100, 0.2% SDS, 1 mM PMSF, 5 μg/ml leupeptin, 
2 μg/ml aprotinin, and 1 mM DTT. Solubilized proteins were diluted with 
equal volume of lysis buffer without detergents and immunoprecipitated 
with the antibody to synaptotagmin-12 or preimmune serum, as described 
in Immunoprecipitations. For in vitro phosphorylation of native synaptotagmin-
12, brain proteins were extracted in 1% of Triton X-100 and immunopre-
cipitated with synaptotagmin-12 antibody or preimmune serum. 
Immunoprecipitates were extensively washed and incubated for 10 min at 
37°C with 50 μl of rat brain cytosol (10 mg/ml in Tris buffer without prote-
ase inhibitors) mixed with 2.5 mM ATP and 20 μCi γ-[
32P]ATP alone with 
addition of 0.1 mM cAMP, 0.1 mM cGMP, or 1 mM Ca
2+. For in vitro 
phosphorylation of recombinant proteins, 30 μg of each GST-fusion pro-
tein immobilized on glutathione–Sepharose beads were mixed with 500 μl 
of reaction mixture containing 50 mM Hepes, pH 7.2, 100 mM NaCl, 
4 mM EGTA, 2 mM MgCl2, 50 units of catalytic subunit of PKA (Sigma-
  Aldrich), 1 mM ATP, and 10 μCi γ-[
32P]ATP and incubated for 30 min at 
30°C. The proteins attached to the beads were then washed three times 
with Hepes buffer (50 mM Hepes, pH 7.2, 100 mM NaCl, 4 mM EGTA, 
2 mM MgCl2, 2 mM sodium orthovanadate, 10 mM sodium pyrophos-
phate, and 50 mM NaF) and analyzed by SDS- PAGE. For detection, gels 
were dried and exposed to x-ray ﬁ  lm for 24–48 h at −80°C.
Electrophysiology
Cortical neurons were infected with lentiviruses encoding wild-type 
  synaptotagmin-12, -12-S97A, or GFP and analyzed at 14–17 DIV (9–12 d 
after infection). Because efﬁ  ciency of lentivaral infections exceeded 95% 
(as determined by GFP ﬂ  uorescence and immunocytochemistry with anti-
body to synaptotagmin-12), we randomly selected the neurons for whole-
cell recording assuming that most presynaptic inputs in infected cultures are 
formed by neurons expressing recombinant protein of interest. Inhibitory 
synaptic responses were triggered by 1-ms current injection (900 μA) 
through a local extracellular electrode (FHC, Inc.) and recorded in a whole-
cell mode using Multiclamp 700A ampliﬁ  er (Axon Instruments, Inc.). All ex-
periments were performed at room temperature. The frequency, duration, 
and magnitude of extracellular stimulus were controlled with Model 2100 
Isolated Pulse Stimulator (A-M Systems, Inc.). The whole-cell pipette solution 
contained 135 mM CsCl2, 10 mM Hepes, 1 mM EGTA, 1 mM Na-GTP, 
4 mM Mg-ATP, and 1 mM QX-314, pH 7.4. The bath solution contained 
140 mM NaCl, 5 mM KCl, 0.5 mM or 2 mM CaCl2, 0.8 mM MgCl2, 
10 mM Hepes, and 10 mM glucose, pH 7.4. Excitatory AMPA and NMDA 
currents were suppressed by the addition of 50 μM APV and 20 μM 
CNQX to the bath solution. Spontaneous mIPSCs were monitored in the 
presence of 1 μM tetrodotoxin to block action potentials. Forskolin (Sigma-
Aldrich) was used at 50 μM. The currents were sampled at 10 kHz and 
analyzed off-line using pClamp9 (Axon Instruments, Inc.) and Origin7 (Mi-
crocal, Inc.) software. mIPSCs event detection was performed with pClamp 
template search function using a template constructed by averaging >100 
manually collected individual mIPSCs. Statistical analysis was performed 
with t test; ***, P ≤ 0.001. All data are shown as the mean ± the SEM.
Miscellaneous
Production of recombinant lentiviruses, phospholipid-binding assays, de-
glycosylation, and immunoblotting were performed as previously described 
(Shin et al., 2003; Han et al., 2004; Maximov and Südhof, 2005).
Online supplemental material
Fig. S1 shows localization of synaptotagmin-12 in brain slices. Fig. S2 
shows the effect of Forskolin on evoked release in inhibitory synapses of 
cultured cortical neurons. Online supplemental material is available at 
http://www.jcb.org/cgi/content/full/jcb.200607021/DC1.
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